Feb. 24, 2005 — The U.S. Food and Drug Administration (FDA) approved in November and December 2004 revisions to safety labeling to advise healthcare professionals of the following changes: use of ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Norditropin® FlexPro® is a dial-a-dose pen containing the active ...
Eddie held up Bryan the Lion, a stuffed animal with its very own tiny plush injector pen and little blue stars stitched onto its fuzzy body. "The stars are where we do the shots," his dad said, ...
With a late-stage trial win for its Norditropin heir in hand, Novo Nordisk is making good on plans to boost its profile in the realm of rare disease. Over the weekend, Novo unveiled data from the ...
To earn CME related to this news article, click here. January 7, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of sudden death reports in pediatric ...
Lumos Pharma’s oral treatment for moderate pediatric growth hormone deficiency has failed to match up to Novo Nordisk’s injected drug Norditropin at the interim analysis of a phase 2 trial. But with ...
Truth matters. Community matters. Your support makes both possible. LAist is one of the few places where news remains independent and free from political and corporate influence. Stand up for truth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback